Literature DB >> 26823741

Level of circulated microRNA-421 in gastric carcinoma and related mechanisms.

Guodong Zhao1, Liang Xu1, Limei Hui2, Jianjun Zhao3.   

Abstract

As one of the most popular and deadly malignant tumors, gastric cancer still has difficulty in early-diagnosis. Recently the level of circulated DNA related with tumors can be used for diagnosis. MicroRNA-421 (miR-421) has been found to be up-regulated in tumor cells. Whether peripheral miR-421 can be used as a marker for diagnosis of gastric carcinoma, however, remains unclear. The expression level of miR-421 in both gastric cancer and normal people were firstly quantified. We then performed in vitro transfection of gastric carcinoma cell line to potentiate or silence miR-421 level. Cell apoptosis and apoptotic protein levels were quantified by flow cytometry and Western blotting, respectively. MiR-421 level in the peripheral blood of gastric cancer patients was significantly elevated. In gastric cancer cell line, the up-regulation of miR-421 significantly inhibited cell apoptosis. The silencing of miR-421 promoted cell apoptosis. Such anti-apoptotic role of miR-421 was accomplished by inhibiting caspase 3, up-regulating Bcl-2 and inhibiting Bax. MiR-421 was up-regulated in both tumor tissue and peripheral blood, and can modulate cell apoptosis. Circulated miR-421 can work as a serological marker for early diagnosis of gastric cancer.

Entities:  

Keywords:  Bax and Bcl-2; Gastric carcinoma; caspase 3; cell apoptosis; circulated microRNA-421

Mesh:

Substances:

Year:  2015        PMID: 26823741      PMCID: PMC4713527     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

1.  E2F1-dependent miR-421 regulates mitochondrial fragmentation and myocardial infarction by targeting Pink1.

Authors:  Kun Wang; Lu-Yu Zhou; Jian-Xun Wang; Yin Wang; Teng Sun; Bing Zhao; Yong-Jie Yang; Tao An; Bo Long; Na Li; Cui-Yun Liu; Ying Gong; Jin-Ning Gao; Yan-Han Dong; Jian Zhang; Pei-Feng Li
Journal:  Nat Commun       Date:  2015-07-17       Impact factor: 14.919

2.  MicroRNA profiling of the intestine during hypothermic circulatory arrest in swine.

Authors:  Wei-Bin Lin; Meng-Ya Liang; Guang-Xian Chen; Xiao Yang; Han Qin; Jian-Ping Yao; Kang-Ni Feng; Zhong-Kai Wu
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

Review 3.  MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.

Authors:  Parham Jabbarzadeh Kaboli; Asmah Rahmat; Patimah Ismail; King-Hwa Ling
Journal:  Pharmacol Res       Date:  2015-05-07       Impact factor: 7.658

4.  Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues.

Authors:  Junming Guo; Ying Miao; Bingxiu Xiao; Rong Huan; Zhen Jiang; Dan Meng; Yanjun Wang
Journal:  J Gastroenterol Hepatol       Date:  2008-11-03       Impact factor: 4.029

5.  miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4.

Authors:  Liang Chen; Yanping Tang; Jian Wang; Zhongjie Yan; Ruxiang Xu
Journal:  Biochem Biophys Res Commun       Date:  2013-05-23       Impact factor: 3.575

Review 6.  Non-coding RNAs and gastric cancer.

Authors:  Pei-Fei Li; Sheng-Can Chen; Tian Xia; Xiao-Ming Jiang; Yong-Fu Shao; Bing-Xiu Xiao; Jun-Ming Guo
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 7.  Circulating Cell-Free Tumour DNA in the Management of Cancer.

Authors:  Glenn Francis; Sandra Stein
Journal:  Int J Mol Sci       Date:  2015-06-19       Impact factor: 5.923

8.  MicroRNA-22 impairs anti-tumor ability of dendritic cells by targeting p38.

Authors:  Xue Liang; Yu Liu; Shiyue Mei; Miaomiao Zhang; Jiaxuan Xin; Yuan Zhang; Rongcun Yang
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

Review 9.  Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease.

Authors:  Mario Notari; Julián Pulecio; Ángel Raya
Journal:  Biomed Res Int       Date:  2015-06-28       Impact factor: 3.411

10.  Synthetic pre-microRNAs reveal dual-strand activity of miR-34a on TNF-α.

Authors:  Boris Guennewig; Martina Roos; Afzal M Dogar; Luca F R Gebert; Julian A Zagalak; Valentina Vongrad; Karin J Metzner; Jonathan Hall
Journal:  RNA       Date:  2013-11-18       Impact factor: 4.942

View more
  5 in total

Review 1.  Noncoding RNAs in gastric cancer: Research progress and prospects.

Authors:  Meng Zhang; Xiang Du
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

Review 2.  Improving the Early Diagnosis of Gastric Cancer.

Authors:  Robert J Huang; Joo Ha Hwang
Journal:  Gastrointest Endosc Clin N Am       Date:  2021-07

Review 3.  MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives.

Authors:  Alexander Link; Juozas Kupcinskas
Journal:  World J Gastroenterol       Date:  2018-08-14       Impact factor: 5.742

4.  Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.

Authors:  Xiwen Liao; Xiangkun Wang; Ketuan Huang; Chengkun Yang; Tingdong Yu; Chuangye Han; Guangzhi Zhu; Hao Su; Rui Huang; Tao Peng
Journal:  Cancer Manag Res       Date:  2018-08-10       Impact factor: 3.989

5.  Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer.

Authors:  Jianlin Chen; Lihua Wu; Yifan Sun; Qi Yin; Xianhua Chen; Siqun Liang; Qingyan Meng; Haihua Long; Fangying Li; Changjun Luo; Xiaorong Xiao
Journal:  PeerJ       Date:  2019-06-17       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.